Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 48 min 27 sec ago

Cardinal Health To Acquire Cordis, A Worldwide Leader In Cardiac And Endovascular Medical Products For $1.944 Billion In Cash

Tue, 03/10/2015 - 15:44
Significantly advances Cardinal Health's offering of interventional cardiology and endovascular solutions for integrated health systems and their patients Creates immediate global scale and scope Fiscal 2017, first full post-close year, accretion is ...
Devices, Interventional, Cardiology, Mergers & Acquisitions
Cardinal Health, Cordis

SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants

Mon, 03/09/2015 - 13:39
International Journal of Spine Surgery reports iFuse Implant System® provides superior clinical outcomes compared to non-surgical management in patients with SI joint dysfunction due to degenerative sacroiliitis or SI joint disruptions SAN JOSE, Cal...
Devices, Orthopaedic, Neurosurgery
SI-BONE, iFuse Implant System, spine surgery

Ceterix Announces Publication of Studies Demonstrating Advantages of Meniscus Repair With Minimally Invasive Orthopaedic Suturing Device

Fri, 03/06/2015 - 15:03
Technology Offers Potential to Improve Repairs, Extend Repair to Additional Tear Types MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Ceterix® Orthopaedics, Inc., a developer of novel surgical tools for minimally invasive soft tissue pr...
Devices, Orthopaedic
Ceterix Orthopaedics, NovoStitch, suture passer, Arthroscopy

Sunshine Heart Provides Update on U.S. Pivotal Study of C-Pulse(R) Heart Assist System

Fri, 03/06/2015 - 14:55
EDEN PRAIRIE, Minn., March 6, 2015 -- (Healthcare Sales & Marketing Network) -- Sunshine Heart, Inc. (SSH) today announced an update on COUNTER HF(TM), the Company's U.S. pivotal study which is a prospective, randomized, multi-center, controlled study eval...
Devices, Cardiology
Sunshine Heart, COUNTER HF, C-Pulse system, balloon counterpulsation

Second Sight Announces Successful First Implants of the Argus(R) II Retinal Prosthesis System at Two New Centers in Italy

Thu, 03/05/2015 - 13:24
SYLMAR, Calif.--(Healthcare Sales & Marketing Network)--Second Sight Medical Products, Inc. (Nasdaq: EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide functional vision to blind pat...
Devices, Ophthalmology
Second Sight Medical Products, Argus II, Retinal Prosthesis

Tetraphase Pharmaceuticals Appoints Maria Stahl as Senior Vice President and General Counsel

Thu, 03/05/2015 - 13:16
WATERTOWN, Mass., March 5, 2015 -- (Healthcare Sales & Marketing Network) -- Tetraphase Pharmaceuticals, Inc. (TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, to...
Biopharmaceuticals, Personnel
Tetraphase Pharmaceuticals, eravacycline

Mazor Robotics Renaissance(R) Guidance System Helping Patients with OCD

Thu, 03/05/2015 - 13:12
ORLANDO, Fla., March 5, 2015 -- (Healthcare Sales & Marketing Network) -- Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain surgery, announced today the f...
Devices, Neurosurgery
Mazor Robotics, Renaissance Guidance System, neurostimulator

CASI Pharmaceuticals Appoints Rong Chen, MD, Ph.D. As Chief Medical Officer

Wed, 03/04/2015 - 14:00
ROCKVILLE, Md., March 4, 2015 -- (Healthcare Sales & Marketing Network) -- CASI Pharmaceuticals, Inc. (CASI), a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and othe...
Biopharmaceuticals, Personnel
CASI Pharmaceuticals

Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy

Wed, 03/04/2015 - 13:53
Bavarian Nordic to receive up to $975 million, inclusive of $60 million upfront and potential exercise payment; potential development, regulatory and commercialization milestone payments; additional tiered double-digit royalties on future sales KVISTGAA...
Biopharmaceuticals, Licensing, Oncology
Bristol-Myers Squibb, Bavarian Nordic, PROSTVAC, prostate cancer

Boston Scientific Elects Charles J. Dockendorff And Stephen P. MacMillan To Board Of Directors

Wed, 03/04/2015 - 00:35
MARLBOROUGH, Mass., March 3, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) announces the election of Charles J. Dockendorff and Stephen P. MacMillan to its board of directors, effective April 1, 2015. Two curr...
Devices, Personnel
Boston Scientific

ArtVentive Medical Group, Inc. Announces First Use of ArtVentive EOS(TM) in the United States

Tue, 03/03/2015 - 13:59
CARLSBAD, Calif.--(Healthcare Sales & Marketing Network)--ArtVentive Medical Group, Inc. (OTC Bulletin Board: AVTD) announced today the first use of its Endoluminal Occlusion System (EOS™) in the United States at The Johns Hopkins Hospital in Baltimore, MD...
Devices, Interventional
ArtVentive Medical Group, Endoluminal Occlusion System

First Patient Treatment with the CyberKnife(R) M6(TM) System and the InCise(TM) Multileaf Collimator Has Been Completed

Tue, 03/03/2015 - 13:51
Patient with Brain Tumor Received Extremely Precise Treatment in Reduced Time SUNNYVALE, Calif. , March 3, 2015 (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) announced today that the first patient treatment has been completed usi...
Devices, Oncology, Neurosurgery
Accuray, CyberKnife, InCise MLC, radiosurgery, radiotherapy

Oraya Therapeutics' AMD Radiotherapy Device Receives New Indication of Use for Choroidal Metastases

Tue, 03/03/2015 - 13:41
NEWARK, Calif.--(Healthcare Sales & Marketing Network)--Oraya Therapeutics announced today that the Oraya IRay® Radiotherapy system has received a CE Mark extension for the treatment of choroidal metastases, a cancer in the eye, originating most common...
Devices, Oncology, Regulatory
Oraya Therapeutics, Oraya IRay, Radiotherapy

Caren Mason Appointed President and CEO of STAAR Surgical Company

Tue, 03/03/2015 - 13:35
Accomplished Leader Brings Broad Expertise and Proven Track Record of Building Successful Healthcare Companies Elected to STAAR's Board of Directors in June 2014; Serves as Chair of Recently Formed Quality & Regulatory Committee MONROVIA, Calif., Mar...
Devices, Ophthalmology, Personnel
STAAR Surgical, Implantable Collamer Lens, intraocular lens

Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion

Mon, 03/02/2015 - 15:33
Combined Business to Advance Patient Care with Leading Solutions Across Major Urology Categories MARLBOROUGH, Mass., March 2, 2015 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) today announced that it has entered into...
Devices, Urology, Mergers & Acquisitions
Boston Scientific, Endo International, American Medical Systems

Mersana Raises $35 Million in Series B Financing and Appoints Anna Protopapas as President and Chief Executive Officer

Mon, 03/02/2015 - 15:28
Funding to advance its internal pipeline First Fleximer® antibody-drug conjugate IND to be filed in 2015 CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Mersana Therapeutics, Inc., announced today that it raised $35 million in Series B-...
Devices, Drug Delivery, Venture Capital, Personnel
Mersana Therapeutics, Fleximer, antibody-drug conjugate

Tryton Medical Announces Publication of Data from Pivotal Trial for Tryton Side Branch Stent in Journal of American College of Cardiology

Mon, 03/02/2015 - 13:43
Results from largest study in treatment of coronary bifurcations demonstrate reductions in TVF and side branch percent stenosis in intended population of patients with complex lesions involving significant side branches DURHAM, N.C.--(Healthcare Sales &...
Devices, Interventional Cardiology
Tryton Medical, Side Branch Stent, coronary bifurcation

Macrocure Hires Dr. Ramesh Tharuvai, Ph.D. as Vice President, Operations

Mon, 03/02/2015 - 13:37
PETACH TIKVA, Israel, March 2, 2015 -- (Healthcare Sales & Marketing Network) -- Macrocure Ltd. (MCUR), a clinical-stage biopharmaceutical company focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds, today announce...
Biopharmaceuticals, Wound Care, Personnel
Macrocure

FDA Approves Allergan’s NATRELLE INSPIRA(TM) Round Gel-Filled Breast Implants

Fri, 02/27/2015 - 15:05
NATRELLE INSPIRA™ Represents Company’s Latest Innovation in Breast Implants Provides New Implant Option for Surgeons and Patients Seeking Reconstruction, Augmentation or Revision Surgery IRVINE, Calif.--(Healthcare Sales & Marketing Network)--Allerg...
Devices, FDA
Allergan, NATRELLE INSPIRA, breast implant

Chiasma Announces Completion of $70 Million Series E Financing

Fri, 02/27/2015 - 14:49
NEWTON, Mass. and JERUSALEM, Feb. 27, 2015 -- (Healthcare Sales & Marketing Network) -- Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closin...
Biopharmaceuticals, Venture Capital
Chiasma, octreotide capsules, acromegaly

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong